lool ventures

Lool Ventures, established in 2012, is a Tel Aviv-based venture capital firm focusing on early-stage investments in Israel's technology sector. The firm specializes in disruptive technology, with a particular interest in web and media, and seeks to support visionary founders dedicated to improving the world or an industry. Lool Ventures typically invests in at least 20 companies per fund, aiming to work with startups for a minimum of five years. Their investment focus includes smart cities, autonomous cars, artificial intelligence, and machine learning.

Roy Katzenelson

Principal

Yair Kfir

CFO

Avichay Nissenbaum

General Partner

Tony Saigh

Partner

Maya Szutan-Azoulay

Partner

Dina Walker

Investor

Reut Zeiri

Principal

Past deals in Mental Health

Eleos Health

Series C in 2025
Eleos Health develops innovative health technology solutions aimed at enhancing decision-making for clinicians in the behavioral health sector. The company's AI-powered Speech-to-Insights system operates during mental health sessions to analyze voice data in real time. By gathering insights on patients through this voice technology, Eleos Health enables clinicians to deliver personalized, efficient, and cost-effective care. The automated nature of the system helps streamline the clinical process, ultimately supporting mental health professionals in providing the necessary care and support for their patients.

Eleos Health

Series B in 2023
Eleos Health develops innovative health technology solutions aimed at enhancing decision-making for clinicians in the behavioral health sector. The company's AI-powered Speech-to-Insights system operates during mental health sessions to analyze voice data in real time. By gathering insights on patients through this voice technology, Eleos Health enables clinicians to deliver personalized, efficient, and cost-effective care. The automated nature of the system helps streamline the clinical process, ultimately supporting mental health professionals in providing the necessary care and support for their patients.

Eleos Health

Series A in 2022
Eleos Health develops innovative health technology solutions aimed at enhancing decision-making for clinicians in the behavioral health sector. The company's AI-powered Speech-to-Insights system operates during mental health sessions to analyze voice data in real time. By gathering insights on patients through this voice technology, Eleos Health enables clinicians to deliver personalized, efficient, and cost-effective care. The automated nature of the system helps streamline the clinical process, ultimately supporting mental health professionals in providing the necessary care and support for their patients.

Inner Cosmos

Seed Round in 2022
Inner Cosmos LLC is a neurotechnology company based in New Haven, Connecticut, focused on developing a brain-computer interface aimed at treating mood disorders. Established in 2016, the company has created a digital pill that utilizes imperceptible microstimulation to rebalance brain networks. This innovative device delivers precise electrical stimulation to the prefrontal cortex, facilitating a gradual rebalancing of neural activity. By providing a hyper-personalized and minimally invasive alternative, Inner Cosmos seeks to reduce the reliance on traditional antidepressants and neurological medications, offering a new approach to managing cognitive disorders.

Eleos Health

Seed Round in 2021
Eleos Health develops innovative health technology solutions aimed at enhancing decision-making for clinicians in the behavioral health sector. The company's AI-powered Speech-to-Insights system operates during mental health sessions to analyze voice data in real time. By gathering insights on patients through this voice technology, Eleos Health enables clinicians to deliver personalized, efficient, and cost-effective care. The automated nature of the system helps streamline the clinical process, ultimately supporting mental health professionals in providing the necessary care and support for their patients.

Inner Cosmos

Venture Round in 2020
Inner Cosmos LLC is a neurotechnology company based in New Haven, Connecticut, focused on developing a brain-computer interface aimed at treating mood disorders. Established in 2016, the company has created a digital pill that utilizes imperceptible microstimulation to rebalance brain networks. This innovative device delivers precise electrical stimulation to the prefrontal cortex, facilitating a gradual rebalancing of neural activity. By providing a hyper-personalized and minimally invasive alternative, Inner Cosmos seeks to reduce the reliance on traditional antidepressants and neurological medications, offering a new approach to managing cognitive disorders.

Eleos Health

Seed Round in 2020
Eleos Health develops innovative health technology solutions aimed at enhancing decision-making for clinicians in the behavioral health sector. The company's AI-powered Speech-to-Insights system operates during mental health sessions to analyze voice data in real time. By gathering insights on patients through this voice technology, Eleos Health enables clinicians to deliver personalized, efficient, and cost-effective care. The automated nature of the system helps streamline the clinical process, ultimately supporting mental health professionals in providing the necessary care and support for their patients.
Spot something off? Help us improve by flagging any incorrect or outdated information. Just email us at support@teaserclub.com. Your feedback is most welcome.